Hi @roysavio, If you are asking about cost of acquisition of Raymond Lifestyle for capital gains calculations, if and when you sell, please read the below article.
Posts in category Value Pickr
Raymond – The Complete Man (11-09-2024)
I needed a little help as an investor in Raymond (pre demerger).
The shareholders got four equity shares of Raymond Lifestyle for every five shares held in Raymond Limited.
If my earlier purchase price of Raymond was Rs 500 (hypothetically, pre demerger), how do I apportion this purchase price between Raymond Limited and Raymond Lifestyle? If there are any articles/blogs around this, please share the links. Thanks!
Investment in the ancillaries, or ancillaries of ancillaries-vendors of famous companies (11-09-2024)
Just like that. Everything need not be reasonable. Somethings must be learn by experience
Dreamfolks services limited( DFS) (11-09-2024)
They will not be opening eateries in the highway.
They will be using their existing proprietary technology to provide food/combos to the card holders (DreamFolks subscription) in already existing third party highway eateries.
A good natural progression for them.
SWAN ENERGY LIMITED (SEL): The company focussing on sectors with strong tailwinds (11-09-2024)
If Triumph Offshore, a subsidiary of Swan Energy, sells its Floating Storage and Regasification Unit (FSRU), it could impact Swan LNG’s operations and future revenue streams. The FSRU plays a key role in Swan LNG’s operations, as it is used for importing and regasifying liquefied natural gas (LNG) at the Jafrabad terminal in Gujarat.
Here are some potential impacts:
Operational Challenges for Swan LNG: Swan LNG depends on Triumph’s FSRU for LNG import operations. Selling the FSRU would require Swan to either lease or purchase a replacement, which could delay or disrupt the terminal’s operations. The Jafrabad terminal, scheduled to operate with a tolling model, would need this infrastructure to continue functioning.
Revenue Loss: Triumph Offshore has already generated substantial revenue by chartering out the FSRU before the full commissioning of Swan LNG. If the FSRU is sold, Swan could lose a significant revenue stream unless a new agreement is formed to continue using the asset on a lease basis.
Increased Costs: Selling the FSRU could result in increased operational costs for Swan LNG. They might need to lease a similar unit at a higher cost or invest in new infrastructure, impacting profitability in the short term.
However, if the FSRU sale is accompanied by plans for a new or more advanced unit, or if Swan Energy enters into a favorable lease agreement, the impact could be mitigated.
Investing Basics – Feel free to ask the most basic questions (11-09-2024)
It will be a LTCG as your older shares will be sold out first as @ChaitanyaC mentioned.
Investing Basics – Feel free to ask the most basic questions (11-09-2024)
It will be a LTCG as your older shares will be sold out first as @ChaitanyaC mentioned.
Investing Basics – Feel free to ask the most basic questions (11-09-2024)
Yes first in first out
Investing Basics – Feel free to ask the most basic questions (11-09-2024)
Yes first in first out
Ranvir’s Portfolio (11-09-2024)
Zydus Wellness –
Q1 FY 25 concall and results highlights –
Revenues – 839 vs 699 cr, up 20 pc ( volume growth @ 17 pc )
Gross margins – 55.5 vs 52.4 pc
EBITDA – 155 vs 116 cr, up 33 pc ( margins @ 18 vs 17 pc ). Other expenses were up 27 pc because of hiring of strategy consultant. Without this, other expenses would have only risen by 6 pc
PAT – 147 vs 110 cr, up 34 pc
Have repaid all their Debts. Company is now net cash cash positive
Company’s brands with their Mkt rank –
Sugarfree – No 1 – with 96 pc mkt share in sugar substitutes
Glucon D – No 1 – with 60 pc mkt share
Complan – No 5 – with 5 pc mkt share
ImLite – NA – new product category ( a unique blend of sugar + stevia )
Nycil – No 1 – with 35 pc mkt share in prickly heat powder
Everyouth – No 1 – in peel off masks and scrubs. No 5 in face wash
Nutralite – NA – has no organised peer in Fat spread category
Harsh summers in Q1 helped in the growth of seasonal products like – Glucon D and Nycil
Seeing a pickup in rural demand – lowering the rural – urban consumption gap
The personal care portfolio ( Everyouth + Nycil ) of the company saw a massive growth of 42 pc YoY !!!
Food and nutrition ( Sugarfree + Nutralite + Complan + Glucon D ) also grew strongly @ 15 pc YoY. Nutralite portfolio grew in single digits
Launched the following product extensions in Q1 –
Complan ImmunoGro – in select states
Everyouth Pink Clay, Charcoal infused anti pollution facewash, scrub and facewash
Nutralite – Tandoori Mayo spread
Nutralite – carrot and cucumber sandwich spread
Nycil soap with 4 variants in International Mkts. The 4 variants are – Aqua Mint, Neem and Aloe Vera, Lime and Sandal
Have lined up four more launches in the coming Qtrs
Company increased their A&P spends by 19 pc in Q1 ( to plough back some of the GM expansion gains )
Everyouth face scrub grew by 14 pc in Q1 and maintained its leadership position with 46 pc mkt share vs 43 pc YoY
Everyouth Peel off grew by 21 pc in Q1 and maintained its leadership position with 78 pc mkt share vs 76 pc YoY
Nycil prickly heat powder grew by 20 pc – led by harsh summers and continuous brand advertisements
Company intends to go back to 17-18 pc kind of EBITDA margins on a full year basis over the next 2-3 yrs
E-Comm now constitutes aprox 10 pc of company’s sales
Company has changed the formulation of SugarFree gold from Aspartame to Sucralose + Chromium. Chromium is known to reduce the blood sugar levels. This should help the company overcome the negative perception around Aspartame
Q2 and Q3 are generally slow for the company. 1/3rd of company revenues comes from these Qtrs. 2/3rd comes from Q1 and Q4. This causes loss of operating leverage in Q2+Q3 and hence the margins correct. However over the medium term, company is sticking to their 17-18 pc kind of EBITDA margins guidance for full FY
Company is confident of achieving double digit growth in topline for FY 25
Disc: initiated a tracking position, monitoring, biased, not SEBI registered, not a buy / sell recommendation